Product description

A CLINICALLY BASED FORMULATION FOR THE MANAGEMENT OF GLAUCOMA
Optoaspis is a novel nutritional supplement for the management of glaucoma. It has a binary mechanism of action in managing  and slowing the progression of patients with glaucoma. Optoaspis is based on solid clinical research and has a holistic approach. In addition, Optoaspis is produced with a controlled release technology (retard form) that permits the maintenance of active ingredients in blood circulation at stable quantities, resulting in a prolonged treatment duration and availability of the ingredients.
Read more

Specifications

More products from Aniva International SA

View all our products (10)

Products from other suppliers